Glaucoma Therapeutics Market Analysis, Share, Size, Development and Demand Forecast to 2023

Global Glaucoma Therapeutics Market, Share, Size, Development
and Demand Forecast to 2023
Glaucoma is a disease of eye which is caused by excessive increase of fluid pressure within the eye. Glaucoma
is caused due to mechanical compression or decreased blood flow in the optic nerve of the patient’s eye. If not
treated properly, it may lead to mild loss of vision and even blindness. Treatment of glaucoma includes laser
therapies, pharmaceutical drugs and surgical procedures.
Ocular hypertension is one of the major causes due to which glaucoma occurs in patients. Glaucoma mostly
occurs at the age over 40, but it may also occur in children, young adults, and infants. Diagnosis of glaucoma can
be done through a simple eye examination with the help of tonometry, an instrument used for measuring
intraocular pressure, by an ophthalmologists and optometrist. Prevention of glaucoma is difficult; however, if
diagnosed and treated at an early stage, the disease can be controlled by using eye drops prescribed by doctor,
microsurgery or by laser surgery. Glaucoma can damage the vision of the affected eye permanently; in first stage
it decreases the peripheral vision and if not treated, it can lead to blindness.
For more information visit: https://www.psmarketresearch.com/market-analysis/glaucoma-therapeutics-market
The global glaucoma therapeutics market can be divided into two types based on the factor that the disease is
known or not. A known disease called as open angle and the not known disease is closed angle glaucoma. Open
angle glaucoma is painless and tends to develop slowly over time, with no symptoms until the disease progress to
a considerable extent. Whereas, closed angle glaucoma is characterized by redness in eye, sudden eye pain,
vomiting and various other symptoms and it should be treated immediately. On the basis of treatment used to
cure the disease, the global glaucoma therapeutics market can be categorized as beta blockers, prostaglandins,
carbonic anhydrase inhibitors, alpha adrenergic agonists, and fixed dose combinations.
Increase in awareness of glaucoma, medicare coverage of glaucoma patients and demand for combination
glaucoma drugs are some of the major trends that can be seen in global glaucoma therapeutics market.
Request for Table of Content: https://www.psmarketresearch.com/market-analysis/Glaucoma-
Therapeutics-Market/toc-sample
Some of the major factors driving the growth of glaucoma therapeutics market are aging population of developed
countries, development of advanced glaucoma drug delivery devices and rising global healthcare expenditures.
Stringent government regulation and marketing approval, side effects of glaucoma medications and long
development process of the glaucoma products are some of the major factors restraining the growth of global
glaucoma therapeutics market.
North America was the largest glaucoma therapeutics market in 2014, attributed to high per capita expenditure on
healthcare in this region. It is followed by Europe and Asia-Pacific. Asia-Pacific region is also the fastest growing
glaucoma therapeutics market, owing to the aging population of Japan coupled with the increasing healthcare
expenditure of developing countries, such as India and China. Asia-Pacific glaucoma therapeutics market is
© P&S Market Research. All rights reserved 2